Tvardi Therapeutics将亮相BTIG虚拟生物技术会议

华尔街洞察
Jul 15, 2025

作为临床阶段生物制药公司的Tvardi Therapeutics Inc.计划参与2025年7月30日的BTIG虚拟生物技术会议。公司将进行一场炉边谈话,时间为东部时间下午4:40。同时,安排一对一投资者会议。活动聚焦于开发靶向STAT3的新型口服小分子疗法,用于治疗纤维化驱动疾病。会议的网络直播将在Tvardi投资者网站提供。会后重播可访问60天。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10